Craigavon firm Galen set to accelerate growth in rare metabolic disease business with new Galsana brand launch

Craigavon-headquartered pharmaceutical company Galen has launched a new global brand that will support the continued growth and development of its specialist rare metabolic disease business and future innovation across the portfolio.